187 related articles for article (PubMed ID: 19350273)
1. High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.
Hu J; Xu Y; Shen ZZ; Wang Z; Lu Q; Yang GH; Ding ZB; Fan J; Zhou J
J Cancer Res Clin Oncol; 2009 Oct; 135(10):1359-67. PubMed ID: 19350273
[TBL] [Abstract][Full Text] [Related]
2. α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.
Kamiyama T; Takahashi M; Nakanishi K; Yokoo H; Kamachi H; Kobayashi N; Ozaki M; Todo S
World J Gastroenterol; 2012 Jan; 18(4):340-8. PubMed ID: 22294840
[TBL] [Abstract][Full Text] [Related]
3. Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
BMC Cancer; 2013 Jun; 13():306. PubMed ID: 23800357
[TBL] [Abstract][Full Text] [Related]
4. Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus.
Zhou J; Tang ZY; Fan J; Wu ZQ; Li XM; Liu YK; Liu F; Sun HC; Ye SL
J Cancer Res Clin Oncol; 2000 Jan; 126(1):57-61. PubMed ID: 10641751
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high Edmondson grades and portal vein tumor thrombosis.
Guo L; Kuroda N; Toi M; Miyazaki E; Hayashi Y; Enzan H; Jin Y
Oncol Rep; 2001; 8(4):871-6. PubMed ID: 11410801
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of vascular endothelial growth factor in hepatocellular carcinoma for predicting metastasis after curative resection.
Minata M; Harada KH; Kudo M; Ikai I; Nishida N
Oncology; 2013; 84 Suppl 1():75-81. PubMed ID: 23428863
[TBL] [Abstract][Full Text] [Related]
7. Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment.
Tamura Y; Igarashi M; Suda T; Wakai T; Shirai Y; Umemura T; Tanaka E; Kakizaki S; Takagi H; Hiasa Y; Onji M; Aoyagi Y
Dig Dis Sci; 2010 Jul; 55(7):2095-101. PubMed ID: 19731025
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma.
Kaio E; Tanaka S; Kitadai Y; Sumii M; Yoshihara M; Haruma K; Chayama K
Oncology; 2003; 64(1):61-73. PubMed ID: 12457033
[TBL] [Abstract][Full Text] [Related]
9. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of stemness factors Oct4 and Nanog predict liver resection.
Yin X; Li YW; Zhang BH; Ren ZG; Qiu SJ; Yi Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2877-87. PubMed ID: 22461131
[TBL] [Abstract][Full Text] [Related]
11. Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection.
Zhu W; Guo L; Zhang B; Lou L; Lin Z; Zhu X; Ren N; Dong Q; Ye Q; Qin L
Ann Surg Oncol; 2014 Apr; 21(4):1304-13. PubMed ID: 24366422
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
Lin K; Huang Q; Zeng J; Ding Z; Wang L; Chen Z; Guo P; Zeng Y; Zhou W; Liu J
Dig Dis Sci; 2021 Dec; 66(12):4545-4556. PubMed ID: 33723698
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study.
Wang ZL; Liang P; Dong BW; Yu XL; Yu DJ
J Gastrointest Surg; 2008 Feb; 12(2):327-37. PubMed ID: 17943391
[TBL] [Abstract][Full Text] [Related]
14. Prediction of tumor recurrence by α-fetoprotein model after curative resection for hepatocellular carcinoma.
Ding HF; Zhang XF; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Lv Y; Pawlik TM
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):660-666. PubMed ID: 33082065
[TBL] [Abstract][Full Text] [Related]
15. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
16. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
[TBL] [Abstract][Full Text] [Related]
17. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived endothelial cell growth factor (PD-ECGF) is up-regulated in human hepatocellular carcinoma (HCC) and the corresponding hepatitis liver.
Morinaga S; Yamamoto Y; Noguchi Y; Imada T; Rino Y; Akaike M; Sugimasa Y; Takemiya S; Takanashi Y
Hepatogastroenterology; 2003; 50(53):1521-6. PubMed ID: 14571777
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.
Chen L; Shi Y; Jiang CY; Wei LX; Lv YL; Wang YL; Dai GH
Int J Biol Markers; 2011; 26(2):108-16. PubMed ID: 21574155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
